This is the authors' abstract. We don't add key points for this paper.
Alopecia areata (AA) is the most common immune-mediated form of nonscarring hair loss and carries an estimated lifetime risk of 0.7% to 3.8%.1 Increasing evidence has linked AA with adverse pregnancy outcomes. AA is associated with several autoimmune conditions, including systemic lupus erythematosus and vitiligo,2 that are known to increase the risk of adverse pregnancy outcomes (eg, miscarriage, low birth weight, and pre-eclampsia).3 Herein, we conducted a systematic review and meta-analysis to evaluate the association between AA and adverse pregnancy outcomes in women.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Rayner et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: